Prognostic Value of Circulating Endothelial Cells in Glioblastoma Patients: a Pilot Study

References

• StuppR , MasonW , vanden Bent Met al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• KargiotisO , RaJ , KyritsisA. Mechanisms of angiogenesis in gliomas. J. Neurooncol.78(3), 281–293 (2006).
   PubMed Web of Science ®Google Scholar
• LeonS , FolkerthR , BlackP. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer77(2), 362–372 (1996).
   PubMed Web of Science ®Google Scholar
• GoonP , LipG , StonelakeP , BlannA. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia11(8), 771–779 (2009).
   PubMed Web of Science ®Google Scholar
• Ricci-VitianiL , PalliniR , BiffoniMet al.Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.. Nature468(7325), 824–830 (2010).
   PubMed Web of Science ®Google Scholar
• GoonP , LipG , BoosC , StonelakeP , BlannA. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia8(2), 79–88 (2006).
   PubMed Web of Science ®Google Scholar
• BidardF , MathiotC , DegeorgesAet al.Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.21(9), 1765–1771 (2010).
   PubMed Web of Science ®Google Scholar
• MancusoP , ColleoniM , CalleriAet al.Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood108(2), 452–459 (2006).
   PubMed Web of Science ®Google Scholar
• MancusoP , GidaroA , GregatoGet al.Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J. Thromb. Haemost.18(10), 2744–2750 (2020).
   PubMed Web of Science ®Google Scholar
• ZhangX , JiangM , YangJ. Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int. J. Infect. Dis.107, 232–233 (2021).
   PubMed Web of Science ®Google Scholar
• ErdbrueggerU , DhaygudeA , HaubitzM , WoywodtA. Circulating endothelial cells: markers and mediators of vascular damage. Curr. Stem Cell Res. Ther.5(4), 294–302 (2010).
   PubMed Web of Science ®Google Scholar
• GreenfieldJ , JinD , YoungLet al.Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme. Neurosurgery64(5), 819–826 (2009).
   PubMed Web of Science ®Google Scholar
• RafatN , BeckGCh , SchulteJ , TuettenbergJ , VajkoczyP. Circulating endothelial progenitor cells in malignant gliomas. J. Neurosurg.112(1), 43–49 (2010).
   PubMed Web of Science ®Google Scholar
• CatalaaI , HenryR , DillonWet al.Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed.19(4), 463–475 (2006).
   PubMed Web of Science ®Google Scholar
• ReynésG , VilaV , FleitasTet al.Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value. PLoS ONE8(7), e69034 (2013).
   PubMed Web of Science ®Google Scholar
• BeerepootL , MehraN , VermaatJ , ZonnenbergB , GebbinkM , VoestE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann. Oncol.15(1), 139–145 (2004).
   PubMed Web of Science ®Google Scholar
• KawaishiM , FujiwaraY , FukuiTet al.Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel. J. Thorac. Oncol.4(2), 208–213 (2009).
   PubMed Web of Science ®Google Scholar
• BennettI , GuoH , KountouriNet al.Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme. J. Clin. Neurosci.22(11), 1802–1808 (2015).
   PubMed Web of Science ®Google Scholar
• YangY , WangZ , LiuH , ZhouY. Circulating endothelial cells in surgical patients. Cor Vasa.34(4), 359–364 (1992).
   PubMedGoogle Scholar
• CalleriA , BonoA , BagnardiVet al.Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin. Cancer Res.15(24), 7652–7657 (2009).
   PubMed Web of Science ®Google Scholar
• WillettC , BoucherY , di TomasoEet al.Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med.10(2), 145–147 (2004).
   PubMed Web of Science ®Google Scholar
• RonzoniM , ManzoniM , MariucciSet al.Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann. Oncol.21(12), 2382–2389 (2010).
   PubMed Web of Science ®Google Scholar
• BatchelorT , SorensenA , di TomasoEet al.AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell11(1), 83–95 (2007).
   PubMed Web of Science ®Google Scholar
• DingY , GaoZ , JacobsonK , SuffrediniA. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J. Pharmacol. Exp. Ther.335(3), 693–702 (2010).
   PubMed Web of Science ®Google Scholar
• SoenenS , DeMeyer S , DresselaersTet al.MRI assessment of blood outgrowth endothelial cell homing using cationic magnetoliposomes. Biomaterials32(17), 4140–4150 (2011).
   PubMed Web of Science ®Google Scholar
• ArmstrongT , GrantR , GilbertM , LeeJ , NordenA. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro. Oncol.18(6), 779–789 (2016).
   PubMed Web of Science ®Google Scholar
• VezzaniA. VEGF and seizures: cross-talk between endothelial and neuronal environments. Epilepsy Curr.5(2), 72–74 (2005).
   PubMedGoogle Scholar
• CugnoM , BorghiM , LonatiLet al.Patients with antiphospholipid syndrome display endothelial perturbation. J. Autoimmun.34(2), 105–110 (2010).
   PubMed Web of Science ®Google Scholar
• BeijeN , KraanJ , TaalWet al.Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial. Br. J. Cancer113(2), 226–231 (2015).
   PubMed Web of Science ®Google Scholar
• AlexiouG , VartholomatosG , KaramoutsiosA , BatistatouA , KyritsisA , VoulgarisS. Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma. Acta Neurol. Belg.113(1), 7–11 (2013).
   PubMed Web of Science ®Google Scholar